Article
New GSK closer to first U.S. approval with anemia drug for patients on dialysis
Rating:
0.0
Views:
72
Likes:
1
Library:
1
GSK Plc came closer to securing its first drug approval since its consumer health spin-off in July as an expert panel of the U.S. health regulator backed an approval for its drug to treat anemia in some patients with chronic kidney disease (CKD).
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value